Healthtech
5 articles

Biotech & Healthtech
How AI is Revolutionizing Drug Discovery and Treatment
AI-discovered molecules are achieving an 80-90% success rate in Phase I clinical trials, dramatically outperforming traditional methods and signaling a new era for drug development.
Mateo Rossi·September 4, 2026

Biotech & Healthtech
AI achieves 92.6% accuracy in neuroimaging diagnostics
In a silent prospective study of 1,155 clinical studies, NeuroVFM, a new AI model, achieved 92.
Mateo Rossi·August 4, 2026

Biotech & Healthtech
What Are the Ethical Impacts of Personalized Medicine in 2026?
In 1999, the tragic death of Jesse Gelsinger during a gene therapy trial exposed the critical need for robust oversight.
Mateo Rossi·July 21, 2026

Biotech & Healthtech
AI in early drug discovery: Advantages and challenges
AI-discovered molecules have an 80-90% success rate in Phase I clinical trials, a figure substantially higher than historic industry averages, according to PubMed and Nature .
Mateo Rossi·July 19, 2026

Biotech & Healthtech
What is AI in Disease Diagnosis and Why Does it Matter?
In a growing number of cases, AI algorithms are diagnosing diseases from imaging scans with higher accuracy and speed than human radiologists, according to the cdc .
Mateo Rossi·May 29, 2026
